Valnemulin

This classification denotes an antibiotic with the molecular formula C31H52N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2AHC415BQG, chemically known as ((2-((r)-2-amino-3-methylbutyramido)-1,1-dimethylethyl)thio)acetic acid, 8-ester with (3as,4r,5s,6s,8r,9r,9ar,10r)-octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3ah-cyclopentacycloocten-1(4h)-one but generally known as valnemulin, which bears US NIH Compound Identifier 127791. European Medicines Agency schedules Valnemulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00009MIG. The term VALNEMULIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). VALNEMULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule valnemulin under HS 29419000 and SITC 54139. As of Q4 2014, VALNEMULIN remains the US FDA Preferred Term for this commodity. Valnemulin bears US NLM identifiers UMLS ID C0764565 and NCI Concept Code C75151. SMILES: S(CC(=O)OC1C2(C3C(C(C(O)C(C1)(C)C=C)C)(CCC2C)CCC3=O)C)C(CNC(=O)C(N)C(C)C)(C)C.